Evidence map›Paper›PMID 41725971›Full record

ReviewCentral European journal of urology2025

Prostate-specific membrane antigen radioguided surgery in prostate cancer: A narrative review.

Piotr Chuchra, Jakub Karwacki, Akihiro Matsukawa, Bartłomiej Borek, Tomasz Rynkiewicz, Omar Tayara, Bartosz Małkiewicz, Paweł Rajwa, Andrzej Paradysz, Marcin Zyczkowski

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Central European journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Piotr ChuchraDepartment of Urology, Medical University of Silesia, Zabrze, Poland.
Jakub KarwackiDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Poland.
Akihiro MatsukawaDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Austria.
Bartłomiej BorekDepartment of Urology Sosnowiec City Hospital LLP in restructuring, Poland.
Tomasz RynkiewiczPolish Center of Advanced Urology, Department of Urology, St. Anne's Hospital EMC, Piaseczno, Poland.
Omar TayaraSecond Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Bartosz MałkiewiczDepartment of Minimally Invasive and Robotic Urology, University Center of Excellence in Urology, Wroclaw Medical University, Poland.
Paweł RajwaSecond Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Andrzej ParadyszDepartment of Urology, Medical University of Silesia, Zabrze, Poland.
Marcin ZyczkowskiClinic of Urology, Institute of Medical Sciences, University of Opole, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Prostate-specific membrane antigen (PSMA) radioguided surgery (RGS) is being tested to personalize lymph node dissection at radical prostatectomy and in the salvage settings. Material and methods: We conducted a narrative review using the MEDLINE database (via PubMed), selecting key publications on the intravenous administration of PSMA to investigate lymph node involvement during surgery. Results: This review provides an overview of the PSMA-RGS methodology and outcomes. The technique demonstrates high specificity, particularly in Conclusions: PSMA-RGS is feasible and safe in both primary and salvage settings. In appropriately selected patients, it may contribute to longer therapy-free survival (36 months) and prolonged biochemical recurrence-free survival (19 months).

Indexed as

lymph node metastasespelvic lymph node dissectionprostate cancerprostate-specific membrane antigenPSMAradioguided surgery

Identifiers

PMID41725971
PMCPMC12924063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.